Top Markets
#1 TENDIES TENDIES +22.00%
#2 Helium Helium +18.46%
#3 Pons Pons +17.91%
#4 Songbird Songbird +11.38%
#5 OSK OSK +9.78%
#6 MarsCoin MarsCoin +9.53%
#7 Biconomy Biconomy +9.26%
#8 pipedog pipedog +8.20%
#9 Seeker Seeker +7.91%
#10 Lista DAO Lista DAO +7.42%
Coin of the day
TENDIES TENDIES
Settings
Language
ENGLISH
Currency
USD
Theme
Tianjin Tianyao Pharmaceuticals Co., Ltd. Tianjin Tianyao Pharmaceuticals Co., Ltd.

Tianjin Tianyao Pharmaceuticals Co., Ltd.

600488
Rank in Stocks #10130
Tianjin Tianyao Pharmaceuticals Co., Ltd. is a Chinese enterprise primarily... Tianjin Tianyao Pharmaceuticals Co., Ltd. is a Chinese enterprise primarily engaged in the research, manufacturing, and export of active pharmaceutical ingredients (APIs) across the Asian market. The company's core product offerings include APIs and formulated drugs for corticosteroid, cardio cerebrovascular, and analgesic applications. Its extensive portfolio of bulk drug substances encompasses numerous compounds such as dexamethasone and its various salts and esters, prednisone, prednisolone, flucinonide, halcinonide, triamcinolone and its derivatives, clobetasol propionate, betamethasone, and methylprednisolone. Based in Tianjin, China, Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHSE: 600488) operates as a subsidiary of Jinhushen Biomedical Technology Co., Ltd.
Share Price
$0.81151775
Last synced: 2026-08-28
Market Cap
$886.09M
Change (1 day)
-1.75%
Change (1 year)
35.84%
Country
CN
Trade Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488)

Category

Healthcare
Revenue for Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488)
Revenue in Aug 2026 TTM: 0
According to Tianjin Tianyao Pharmaceuticals Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Tianjin Tianyao Pharmaceuticals Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN